<DOC>
	<DOCNO>NCT01449591</DOCNO>
	<brief_summary>This study evaluate safety , tolerability efficacy BFH772 12 week treatment compare active control vehicle patient erythemato-telangiectatic rosacea .</brief_summary>
	<brief_title>Safety , Tolerability Efficacy BFH772 Rosacea Patients</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<criteria>Have persistent facial erythema cheek least moderate severity . Women must able bear child Have 12 inflammatory lesion face Previous treatment facial skin laser electrocauterisation within 2 month prior enter study Have facial hair make difficult evaluate rosacea face Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>BFH772</keyword>
	<keyword>rosacea</keyword>
	<keyword>erythemato-telangiectatic rosacea</keyword>
</DOC>